- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 218
The House gets bigger with $44m second fund
UC Berkeley-focused House Fund II has raised $44m from investors including endowments for the university and the wider University of California ecosystem.
Nov 20, 2019PsiQuantum swings $230m
University of Bristol-founded PsiQuantum has reportedly scooped funding from backers including an Andy Rubin fund as it looks to develop silicon-powered quantum computers.
Nov 19, 2019StimAire implants UAVC funding
UAVenture Capital Fund II has backed University of Arizona spinout StimAire, which is working on neuromodulation-based treatments for conditions including obstructive sleep apnoea.
Nov 19, 2019CL Educate clears university startup funding
The education services provider is set to invest $4.2m in university-based startups in support of open innovation platform Wain Connect.
Nov 19, 2019Siren attracts $10m for series A round
Atlantic Bridge led a round for NUI Galway-founded organisational data investigation spinout Siren, having backed the company's seed round through its University Bridge Fund.
Nov 18, 2019Daily deal net: November 15, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Nov 15, 2019AMP amplifies $16m
UC-backed Congruent Ventures has returned to take part in a series A round for waste recycling robot company AMP Robotics.
Nov 15, 2019Daily deal net: November 14, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Nov 14, 2019Sera Prognostics diagnoses $36m series D
Based on research from Brigham Young University and University of Utah, Sera has added $36m to its funding vault to drive commercialisation of its blood testing system PreTRM.
Nov 14, 2019PMV pinpoints $62m investment
OUP returned for PMV's series C round which the company will use to cement its portfolio of small molecule treatments targeting cancerous p53 mutations.
Nov 14, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


